title: Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks.
abstract: Fibrillin-containing microfibrils are polymeric structures that are difficult to extract from connective tissues. Proteolytic digestion of tissues has been utilized to release microfibrils for study. Few of the molecules that connect microfibrils to other elements in the matrix have been identified. In this study, electron microscopic immunolocalization of anti-versican antibodies in tissues and in extracted microfibrils demonstrated that the C-terminal region of versican is found associated with fibrillin microfibrils. Extraction of microfibrils followed by treatment of microfibrils under dissociating conditions suggested that the versican C terminus is covalently bound to microfibrils. Binding assays using recombinant fibrillin-1 polypeptides and recombinant lectican lectin domains indicated that the versican lectin domain binds to specific fibrillin-1 polypeptides. The versican lectin domain also bound to molecules comigrating with authentic fibrillin-1 monomers in an assay using cell culture medium. In assays using microfibrils, the versican lectin domain demonstrated preferential binding compared with other lecticans. Binding was calcium-dependent. The binding site for versican in microfibrils is most likely within a region of fibrillin-1 between calcium-binding epidermal growth factor-like domains 11 and 21. Human mutations in this region can result in severe forms of the Marfan syndrome ("neonatal" Marfan syndrome). The connection between versican and fibrillin microfibrils may be functionally significant, particularly in cardiovascular tissues.
authors.affiliation: Shriners Hospital for Children and the Department of Biochemistry and Molecular Biology, Oregon Health Sciences University, Portland, Oregon 97201, USA.
authors.forename: Zenzo
authors.initials: Z
authors.lastname: Isogai
authors.forename: Anders
authors.initials: A
authors.lastname: Aspberg
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Keene
authors.forename: Robert N
authors.initials: RN
authors.lastname: Ono
authors.forename: Dieter P
authors.initials: DP
authors.lastname: Reinhardt
authors.forename: Lynn Y
authors.initials: LY
authors.lastname: Sakai
mesh_terms: D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism*; D003238:Connective Tissue / Q000378:metabolism* / Q000648:ultrastructure; D000071838:Fibrillin-1; D000071837:Fibrillins; D006801:Humans; D037181:Lectins, C-Type; D020894:Microfibrils / Q000378:metabolism / Q000648:ultrastructure; D008840:Microfilament Proteins / Q000378:metabolism*; D008855:Microscopy, Electron, Scanning; D016253:Microscopy, Immunoelectron; D053675:Versicans; D054392:Adipokines
chemical_list: D011508:Chondroitin Sulfate Proteoglycans; D000071838:Fibrillin-1; D000071837:Fibrillins; D037181:Lectins, C-Type; D008840:Microfilament Proteins; D053675:Versicans; C000605722:FBN1 protein, human; D054392:Adipokines; C508322:VCAN protein, human